日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Pelodictyon luteolum Homoserine O-acetyltransferase (metX) CSB-YP661534PAAP
CSB-EP661534PAAP
CSB-BP661534PAAP
CSB-MP661534PAAP
CSB-EP661534PAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelodictyon luteolum Histidinol dehydrogenase (hisD) CSB-YP661535PAAP
CSB-EP661535PAAP
CSB-BP661535PAAP
CSB-MP661535PAAP
CSB-EP661535PAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelodictyon luteolum Aspartate carbamoyltransferase (pyrB) CSB-YP661536PAAP
CSB-EP661536PAAP
CSB-BP661536PAAP
CSB-MP661536PAAP
CSB-EP661536PAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelodictyon luteolum Bifunctional purine biosynthesis protein PurH (purH), partial CSB-YP661537PAAP
CSB-EP661537PAAP
CSB-BP661537PAAP
CSB-MP661537PAAP
CSB-EP661537PAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelodictyon luteolum UPF0235 protein Plut_0338 (Plut_0338) CSB-YP661538PAAP
CSB-EP661538PAAP
CSB-BP661538PAAP
CSB-MP661538PAAP
CSB-EP661538PAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelodictyon luteolum 30S ribosomal protein S21 (rpsU) CSB-YP661539PAAP
CSB-EP661539PAAP
CSB-BP661539PAAP
CSB-MP661539PAAP
CSB-EP661539PAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelodictyon luteolum Light-independent protochlorophyllide reductase subunit N (bchN) CSB-YP661540PAAP
CSB-EP661540PAAP
CSB-BP661540PAAP
CSB-MP661540PAAP
CSB-EP661540PAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelodictyon luteolum 30S ribosomal protein S11 (rpsK) CSB-YP661541PAAP
CSB-EP661541PAAP
CSB-BP661541PAAP
CSB-MP661541PAAP
CSB-EP661541PAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelodictyon luteolum 30S ribosomal protein S8 (rpsH) CSB-YP661542PAAP
CSB-EP661542PAAP
CSB-BP661542PAAP
CSB-MP661542PAAP
CSB-EP661542PAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelodictyon luteolum 50S ribosomal protein L22 (rplV) CSB-YP661543PAAP
CSB-EP661543PAAP
CSB-BP661543PAAP
CSB-MP661543PAAP
CSB-EP661543PAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelodictyon luteolum 30S ribosomal protein S7 (rpsG) CSB-YP661544PAAP
CSB-EP661544PAAP
CSB-BP661544PAAP
CSB-MP661544PAAP
CSB-EP661544PAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelodictyon luteolum Ribonuclease 3 (rnc) CSB-YP661545PAAP
CSB-EP661545PAAP
CSB-BP661545PAAP
CSB-MP661545PAAP
CSB-EP661545PAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelodictyon luteolum Putative pterin-4-alpha-carbinolamine dehydratase (Plut_0106) CSB-YP661546PAAP
CSB-EP661546PAAP
CSB-BP661546PAAP
CSB-MP661546PAAP
CSB-EP661546PAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelodictyon luteolum DNA replication and repair protein recF (recF) CSB-YP661547PAAP
CSB-EP661547PAAP
CSB-BP661547PAAP
CSB-MP661547PAAP
CSB-EP661547PAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rat Coproporphyrinogen-III oxidase, mitochondrial (Cpox) CSB-YP661548RA
CSB-EP661548RA
CSB-BP661548RA
CSB-MP661548RA
CSB-EP661548RA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio Mitochondrial translocator assembly and maintenance protein 41 homolog (tamm41) CSB-YP661549DIL
CSB-EP661549DIL
CSB-BP661549DIL
CSB-MP661549DIL
CSB-EP661549DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Pre-mRNA-splicing factor RBM22 (RBM22) CSB-YP661550BO
CSB-EP661550BO
CSB-BP661550BO
CSB-MP661550BO
CSB-EP661550BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Unconventional prefoldin RPB5 interactor (URI1), partial CSB-YP661551BO
CSB-EP661551BO
CSB-BP661551BO
CSB-MP661551BO
CSB-EP661551BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rat CTD nuclear envelope phosphatase 1 (Ctdnep1), partial CSB-YP661552RA
CSB-EP661552RA
CSB-BP661552RA
CSB-MP661552RA
CSB-EP661552RA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Protein FAM161A (FAM161A) CSB-YP661553HU
CSB-EP661553HU
CSB-BP661553HU
CSB-MP661553HU
CSB-EP661553HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×